Cornea

With this expansion, BostonSight reinforces its commitment to advancing care for patients with severe ocular surface disease and irregular corneas.

In a climate of shrinking reimbursements and rising costs, finding your niche isn’t just smart—it’s essential.

The latest in drug and technology developments and updates from July 2025.

Paul Levine, OD, FAAO, FIAOMC, details a pediatric case of high myopia in which the patient's prescription had increased from –5.75 DS OU to OD –7.00 DS, OS –6.75 DS within a year.

The module can be used in combination with Ziemer’s FEMTO LDV Z8 femtosecond laser platform, an all-in-one laser for refractive, cataract, and therapeutic surgery.

Joe Shovlin, OD, FAAO, sat down with Optometry Times to detail a presentation he gave at AOA's Optometry's Meeting 2025.

Laura Holtz, OD, states that although it is a small part of the cornea, the epithelium plays a vital role that affects refractive surgery recommendations, diagnosis of corneal ectasias, and contact lens warpage.

The surgery isn't over until the healing is don

Maxitrol has been the leading corticosteroid/antibiotic combination drop for the treatment of ocular inflammation and bacterial infections for more than 50 years.

Jamie Kuzniar, OD, FAAO, FSLS, has found her niche in specialty contact lenses and individualized care at her practice, Elevate Eye Care + Eyewear.

Methylphenidate is a central nervous system stimulant that is used to treat ADHD, a very common diagnosis in children in the US.

Pantheon Vision’s bioengineered corneal implant aims to tackle issues with the success rate of human donated tissue.

The study compared the quantity and quality of tissue-resident memory T cells in HSV-1 infected corneas that did or did not develop herpes stromal keratitis.

The study findings indicated that lifestyle changes associated with the COVID-19 pandemic were connected to an increase in childhood astigmatisms.

The study evaluated 14 patients that were treated with cultivated autologous limbal epithelial cells (CALEC) and followed them for 18 months.

Urcosmod is a lipid conjugated chemerin peptide agonist of the ChemR23 G-protein coupled receptor, typically found on immune cells of the eye responsible for the inflammatory response.

If approved, Epoxia will be the first epi-on corneal crosslinking on the market.

The study found that 17.4% of Medicare patients needed subspecialized procedures relative to 5.6% of surgeons practicing in rural areas between 2012 and 2022.

The device was created in collaboration with SlitLED and featuring AutoAquire, RemotePilot, and Multi-Slit views.

Misconceptions often lead to missed diagnoses.

Jamie Kuzniar, OD, FAAO, FSLS, shares key takeaways from a case series that investigated higher order aberration reduction in longstanding scleral lens wearers.

Study authors found that central corneal temperature could decrease faster with insufficient recovery time or severe symptoms, indicating a faster evaporation of the tear film.

Abby Gillogly Harsch, OD, FAAO, FSLS, shares a specific complex case of scleral lens fitting that she presented on at this year's GSLS.

RayTrace has been utilized globally by surgeons since 2008.

WAVE Eye Care was developed by EyePrint Prosthetics, Advanced Vision Technologies (AVT), and WAVE Contact Lens System.

The module provides eye care professionals access to advanced thickness mapping and data insights for evaluating epithelial and stromal structures.

This year was brimming with advancements in eye care.

If approved, Glaukos states that Epioxa would be the first FDA-approved, non-invasive corneal cross-linking therapy that does not require removal of the corneal epithelium.

Aurion Biotech announced that Phase 1/2 CLARA trial of AURN001 for corneal edema demonstrated significant dose-dependent efficacy, especially in the high-dose group, with favorable safety and tolerability profiles.